Eczema symptoms
Pro Research Analysisby 
Searched over 200M research papers for "eczema symptoms"
Understanding Eczema Symptoms: A Comprehensive Overview
Prevalence of Eczema Symptoms Worldwide
Eczema, also known as atopic dermatitis, is a chronic skin condition characterized by itchy, inflamed skin. The prevalence of eczema symptoms varies significantly across different regions and age groups. According to the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three, the prevalence of current eczema in children aged 6 to 7 years ranged from 0.9% in India to 22.5% in Ecuador, with high values observed in Asia and Latin America . For adolescents aged 13 to 14 years, the prevalence ranged from 0.2% in China to 24.6% in Colombia, with the highest values in Africa and Latin America . These findings highlight that eczema is a global health issue affecting both developed and developing countries.
Common Symptoms of Eczema
Eczema symptoms typically include redness, itching, dryness, and inflammation of the skin. Severe cases may involve blistering, cracking, oozing, or bleeding . The condition often leads to significant discomfort and can disrupt sleep, particularly in severe cases where symptoms cause sleep disturbances at least one night per week Odhiambo2009Williams1999. Itchiness is the most frequently reported symptom, followed by sleep loss, dryness, and redness .
Psychosocial Impact on Eczema Severity
Psychosocial factors play a crucial role in the severity of eczema symptoms. Stress has been consistently found to exacerbate eczema, while coping strategies and social support do not seem to moderate this effect . Depression is also associated with increased severity of eczema symptoms, with the impact of depression as a consequence of eczema being more significant than its role as an exacerbating factor . Other factors such as illness identity, anger, frustration, and psychosomatic states can also influence symptom severity .
Measurement and Reporting of Eczema Symptoms
The measurement of eczema symptoms in clinical trials varies widely, with itch and sleep loss being the most commonly assessed symptoms . The Harmonising Outcome Measures for Eczema (HOME) initiative has recommended the Patient-Oriented Eczema Measure (POEM) as the preferred instrument for capturing patient-reported symptoms, including itch, sleep loss, dryness, redness, and irritated skin . However, there is a need for further standardization and validation of these measurement tools to ensure consistency across studies .
Eczema in the United States
In the United States, a population-based survey found that 17.1% of individuals reported at least one eczematous symptom, with 10.7% meeting the empirical criteria for eczema and 6% for atopic dermatitis . The prevalence of eczema symptoms was found to decrease with increasing income, and a significant proportion of cases were undiagnosed, indicating that many individuals manage their symptoms with nonprescription remedies .
Conclusion
Eczema is a prevalent and impactful condition worldwide, with symptoms that significantly affect the quality of life of those affected. The variability in symptom prevalence across different regions underscores the importance of considering environmental and psychosocial factors in managing the disease. Standardized measurement and reporting of symptoms are essential for advancing research and improving treatment outcomes. Understanding the multifaceted nature of eczema symptoms can help in developing more effective management strategies and improving the quality of life for patients.
Sources and full results
Most relevant research papers on this topic
DOI